Related Experiment Video
Updated: Aug 9, 2026

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
Stem cells and cystic fibrosis
Massimo Conese1, Joanna Rejman
1Institute for the Experimental Treatment of Cystic Fibrosis, San Raffaele Scientific Institute, Milan, Italy. conese.massimo@hsr.it <conese.massimo@hsr.it>
Abstract:
Although cystic fibrosis at first sight appears to be one of the most obvious human diseases to treat with gene therapy, since it is caused by a single-gene defect and the main affected organ is the lung which is relatively easily accessible, clinical results have thus far been disappointingly limited. At least one cause for this lack of success is the failure to permanently correct the gene defect in addition to the rapid turnover of lung epithelial cells. Alternative approaches therefore involve the search for and use of stem cell populations. This review presents an overview of recent attempts to identify lung- or bone marrow-derived populations of stem cells or progenitor cells and to apply such cells, heterologous or gene-corrected autologous, to colonize the airways while differentiating into functional respiratory columnar epithelial cells. The most successful approaches thus far appear to be obtained with bone marrow-derived cells such as mesenchymal stem cells, although the transdifferentiation rate thus far has been limited to below the 1% level. As an alternative the proven multipotent nature of bronchioalveolar stem cells isolated from lung tissue may provide another promising approach for successful stem cell therapy.
Insights
Gene therapy for cystic fibrosis (CF) has shown limited success due to gene correction challenges. Stem cell therapy, particularly using bone marrow-derived cells, offers a promising alternative for lung regeneration in CF patients.
Area of Science:
- Regenerative Medicine
- Pulmonary Medicine
- Gene Therapy
Background:
- Cystic fibrosis (CF) is a single-gene disorder affecting the lungs, making it a target for gene therapy.
- Despite accessibility, gene therapy for CF has yielded limited clinical success due to challenges in permanent gene correction and rapid lung cell turnover.
Purpose of the Study:
- To review recent advancements in stem cell-based approaches for treating cystic fibrosis.
- To evaluate the potential of lung- and bone marrow-derived stem cells for regenerating functional respiratory epithelium.
Main Methods:
- Review of current literature on stem cell identification and application in CF.
- Analysis of studies using autologous or heterologous stem cells (e.g., mesenchymal stem cells, bronchioalveolar stem cells) for airway colonization and differentiation.
- Assessment of cell transdifferentiation rates and functional outcomes.
Main Results:
- Bone marrow-derived stem cells, such as mesenchymal stem cells, show potential but have limited transdifferentiation rates (below 1%).
- Bronchioalveolar stem cells isolated from lung tissue demonstrate multipotency and offer a promising alternative for stem cell therapy in CF.
Conclusions:
- Stem cell therapy presents a viable alternative to gene therapy for cystic fibrosis, addressing limitations of permanent gene correction.
- Further research into bronchioalveolar stem cells and optimization of bone marrow-derived stem cell applications are crucial for successful CF treatment.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Stem Cell Culture
iPS Cell Differentiation
Induced Pluripotent Stem Cells
Somatic cells are...
Induced Pluripotent Stem Cells
Source And Potency Of Stem Cells

